Insider trades
Dinesh V. Ph D. Patel, CEO of Protagonist Therapeutics PTGX, has filed 0 purchases and 20 sales on the open market. Over the past 12 months that comes to a net sale of $27.4M. The latest trade was on 05/12.
Dinesh V. Ph D. Patel
President and CEO
- First filing
- 23/01/18
- Trades
- 69 trades
- Buys / sales
- 0 / 20
- 12-month net buying
- −$27.4M
- Last trade
- 05/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan · Amendment | 05/12 | 05/14 | 75,000 sh | $100.12 | $7,509,000 | −12.5% | |
| Open-market sale | 05/12 | 05/12 | 75,000 sh | $100.12 | $7,509,000 | −12.5% | |
PTGX | Open-market sale | 03/24–03/25 | 03/25 | 54,700 sh2 trades | $101.00avg. | $5,524,700 | −9.4% |
PTGX | Open-market sale | 01/23–01/27 | 01/27 | 48,273 sh4 trades | $84.18avg. | $4,063,743.02 | −7.8% |
| Open-market sale | 01/20 | 01/21 | 34,438 sh | $82.48 | $2,840,446.24 | −5.6% | |
| Open-market sale | 25/07/25 | 25/07/28 | 10,415 sh | $54.78 | $570,533.7 | −2.0% | |
PTGX | Open-market sale | 25/07/21–25/07/23 | 25/07/23 | 52,444 sh3 trades | $54.92avg. | $2,880,043.79 | −9.0% |
| Open-market sale | 25/02/19 | 25/02/20 | 5,359 sh | $38.18 | $204,606.62 | −1.0% | |
PTGX | Open-market sale | 24/11/25–24/11/26 | 24/11/27 | 100,000 sh2 trades | $46.81avg. | $4,680,749.2 | −19.7% |
| Open-market sale10b5-1 plan | 24/06/07 | 24/06/11 | 35,000 sh | $35.19 | $1,231,650 | −6.4% | |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/02 | 25,000 sh | $28.31 | $707,750 | −4.4% | |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/01 | 30,000 sh | $31.62 | $948,600 | −5.0% | |
| Open-market sale10b5-1 plan | 23/12/13 | 23/12/15 | 75,000 sh | $20.08 | $1,506,000 | −12.3% |